Survivin Determines Cardiac Function by Controlling Total Cardiomyocyte Number
暂无分享,去创建一个
Lars Stegger | Sven Hermann | Paulus Kirchhof | Larissa Fabritz | Michael Schäfers | Bodo Levkau | Alexander Ghanem | Klaus Tiemann | Jörg Stypmann | P. Kirchhof | J. Stypmann | J. Fischer | L. Stegger | M. Schäfers | K. Schmid | A. Ghanem | F. Mehrhof | B. Levkau | U. Flögel | H. Baba | J. Schrader | G. Heusch | E. Conway | L. Fabritz | S. Hermann | K. Tiemann | Jürgen Schrader | Ulrich Flögel | Kurt W Schmid | Naomasa Kawaguchi | N. Kawaguchi | Edward M Conway | P. Hsieh | Hideo A Baba | Jens W Fischer | Jeremias Wohlschlaeger | Petra Keul | Gerd Heusch | J. Neumann | Karin von Wnuck Lipinski | Patrick Hsieh | Yen-Ling Ou | Felix Mehrhof | Marek Matus | Joachim Neumann | J. Wohlschlaeger | P. Keul | K. von Wnuck Lipinski | M. Máťuš | Yen-Ling Ou | Karin von Wnuck Lipinski
[1] R. Agami,et al. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension , 2003, The EMBO journal.
[2] William C Earnshaw,et al. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells , 2003, Journal of Cell Science.
[3] M. Lohse,et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Leevers,et al. Controlling the size of organs and organisms. , 2005, Current opinion in cell biology.
[5] G. Haroske,et al. Part I: Basic Considerations and Recommendations for Preparation, Measurement and Interpretation , 1998, Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology.
[6] G. Biondi-Zoccai,et al. Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction , 2004, Journal of Clinical Pathology.
[7] B. A. French,et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.
[8] M. Buckingham,et al. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. , 2004, Developmental cell.
[9] C. ffrench-Constant,et al. The control of cell number during central nervous system development in flies and mice , 2003, Mechanisms of Development.
[10] G Haroske,et al. 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.
[11] J. Fangusaro,et al. Essential Role for Survivin in Early Brain Development , 2005, The Journal of Neuroscience.
[12] M. Fey,et al. Inflammation-associated Cell Cycle–independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils , 2004, The Journal of experimental medicine.
[13] Tak W. Mak,et al. Pathways of apoptotic and non-apoptotic death in tumour cells , 2004, Nature Reviews Cancer.
[14] C. Adler,et al. Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts , 1996, Virchows Archiv.
[15] A. Winoto,et al. Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis , 2004, The Journal of experimental medicine.
[16] John Calvin Reed,et al. HBXIP functions as a cofactor of survivin in apoptosis suppression , 2003, The EMBO journal.
[17] D. Vaux,et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype , 2000, Current Biology.
[18] E. Ritz,et al. Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension , 2003, Virchows Archiv.
[19] Michael Schäfers,et al. Lack of Myoglobin Causes a Switch in Cardiac Substrate Selection , 2005, Circulation research.
[20] John Miller,et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. , 2006, International journal of cardiology.
[21] Atsushi Takeda,et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. , 2005, Cardiovascular research.
[22] R. Altura,et al. Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. , 2007, Blood.
[23] R. Kitsis,et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.
[24] Richard T. Lee,et al. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. , 2005, The Journal of clinical investigation.
[25] J. Ingelfinger,et al. Is microanatomy destiny? , 2003, The New England journal of medicine.
[26] Guido Kroemer,et al. Cell death by mitotic catastrophe: a molecular definition , 2004, Oncogene.
[27] P. Taylor,et al. Experimental models of developmental programming: consequences of exposure to an energy rich diet during development , 2005, The Journal of physiology.
[28] Richard T. Lee,et al. Biomechanically Induced Gene iex-1 Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation , 2003, Circulation research.
[29] W. Sandritter,et al. Deoxyribonucleic Acid Content (Feulgen Photometry) and Dry Weight (Interference Microscopy) of Normal and Hypertrophic Heart Muscle Fibres , 1964, Nature.
[30] J. Fischer,et al. Integrin-Mediated Transcriptional Activation of Inhibitor of Apoptosis Proteins Protects Smooth Muscle Cells Against Apoptosis Induced by Degraded Collagen , 2006, Circulation research.
[31] N. Hollenberg,et al. Nephron number in patients with primary hypertension. , 2003, Current hypertension reports.
[32] S. Vatner,et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.
[33] C. Mantel,et al. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. , 2004, Blood.
[34] David L. Vaux,et al. IAPs, RINGs and ubiquitylation , 2005, Nature Reviews Molecular Cell Biology.
[35] Xuebiao Yao,et al. Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis* , 2003, Journal of Biological Chemistry.
[36] D. Altieri. Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm , 2004, Journal of cellular biochemistry.
[37] Anjen Chenn,et al. Regulation of Cerebral Cortical Size by Control of Cell Cycle Exit in Neural Precursors , 2002, Science.
[38] P. Anversa,et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. , 2003, Circulation research.
[39] J. Narula,et al. Apoptosis and heart failure: clinical relevance and therapeutic target. , 2005, Journal of molecular and cellular cardiology.
[40] J. Spears,et al. Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarction reperfusion, experimentally reduces infarct size and improves left ventricular function. , 2006, International journal of cardiology.
[41] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.